Tom Piotrowski speaks with Opthea Ltd (OPT) CEO & Managing Director, Dr Megan Baldwin about its recent name change from Circadian Technologies, the surge in its share price over the past six months, and the upcoming results of its Phase 1 trial To view more Executive Series interviews, visit: (VIEW LINK)